Burke Fred 4
4 · Guardian Pharmacy Services, Inc. · Filed Mar 31, 2026
Research Summary
AI-generated summary of this filing
Guardian Pharmacy (GRDN) CEO Fred Burke Converts 1.3M Shares
What Happened Fred Burke (President, CEO and Director) recorded the conversion/exercise of 1,298,826 derivative shares on March 28, 2026. The filing shows an exercise/conversion (transaction code M) of 1,298,826 shares into Class A common stock; no cash price is reported (N/A). This was a conversion of existing Class B shares into Class A shares — not an open‑market buy or sale.
Key Details
- Transaction date: March 28, 2026 (reported on Form 4 filed March 31, 2026).
- Transaction type/code: Exercise/conversion of derivative (M).
- Shares converted: 1,298,826 (reported as both acquired and disposed in the filing, reflecting the conversion).
- Price: N/A (no cash paid/received in the reported conversion).
- Shares owned after transaction: Not specified in the filing.
- Footnote: Per the company’s Amended & Restated Certificate of Incorporation, Burke’s Class B common stock automatically converts one‑for‑one into Class A common stock in substantially equal tranches on March 28, 2026 and September 27, 2026.
- Filing timeliness: Form 4 was filed on March 31, 2026 (the filing lists the March 28, 2026 transaction).
Context This was an automatic conversion of Class B to Class A shares under company charter terms (transaction code M) — not a purchase or sale that signals a change in investment stance. Because the conversion is one‑for‑one and scheduled in tranches, expect a remaining conversion tranche on September 27, 2026 per the filing.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-03-28+1,298,826→ 2,139,239 total - Exercise/Conversion
Class B Common Stock
[F1]2026-03-28−1,298,826→ 1,298,825 total→ Class A Common Stock (1,298,826 underlying)
Footnotes (1)
- [F1]Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.